Estar Medical is a world leader in the fields of biologics and Platelet-Rich Plasma (PRP) therapy and is proud to be at the forefront of the Regenerative Medicine companies with its unique patented, FDA and CE approved technologies that deliver progressive non-surgical healing treatment in multiple applications such as: aesthetics, orthopedics, wound management, dental, cardiology, ophthalmology, veterinary and more. Estar Medical's product portfolio is uniquely designed for easily achieving superior technological, biological & scientific advantages compared to alternative devices in the market. Estar Medical offers an easy-to-use technology platform for creating an effective autologous regenerative medicine solution which is safe, efficient & reproducible. Platelet Rich Plasma (PRP) is a revolutionary non-surgical healing treatment that uses the body’s own growth factors taken from the patient’s own blood to treat and repair damaged soft and hard tissue, promote development of new blood vessels and stimulate the wound healing process. Estar Medical takes this revolutionary approach to the next level with its flagship products: the Tropocells® and Cellenis® PRP technologies being marketed in more than 70 countries worldwide and prides itself of being totally committed to innovation and quality of such unique systems, as well as creating the next generation of its proprietary Tropocells® platform technology. Founded in 1992 by Aaron Esteron - a polymer-science expert, entrepreneur and prolific inventor, Estar Medical is a pioneer in the biologics arena being one of the very first companies to commercialize this unique line of products.